Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Is it possible that a modest XRP investment today could change your financial future? This guide weighs the odds, out...
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Investors are increasingly betting against Wall Street with inverse ETFs. This article explains how these funds work,...
Investing in space stocks is no longer a sci‑fi dream. This guide breaks down where will rocket stock likely head in ...
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
Bitcoin’s calm price action has persisted through February 2026, but traders warn the lull may be masking fading ETF ...
Geneva hosts a fresh round of U.S.-Iran nuclear talks as regional tensions rise. Markets respond with shifts in oil p...